Multivariate analysis of post HSCT outcomes
| Variable . | OS . | RFS . | Relapse . | NRM . | ||||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | SHR (95% CI) . | P . | SHR (95% CI) . | P . | |
| Treatment | ||||||||
| IC without VEN | Reference | Reference | Reference | Reference | ||||
| LIT without VEN | 1.10 (0.58-2.11) | .76 | 1.04 (0.55-1.98) | .90 | 1.97 (0.80-4.83) | .14 | 0.50 (0.18-1.38) | .18 |
| LIT with VEN | 0.71 (0.35-1.43) | .34 | 0.81 (0.42-1.56) | .53 | 1.21 (0.49-3.00) | .68 | 0.54 (0.20-1.43) | .21 |
| HCT-CI Score | ||||||||
| Low-/intermediate-risk (0-2) | Reference | Reference | — | — | ||||
| High-risk (≥3) | 2.09 (1.20-3.65) | .01 | 1.90 (1.11-3.25) | .02 | — | — | ||
| Variable . | OS . | RFS . | Relapse . | NRM . | ||||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | SHR (95% CI) . | P . | SHR (95% CI) . | P . | |
| Treatment | ||||||||
| IC without VEN | Reference | Reference | Reference | Reference | ||||
| LIT without VEN | 1.10 (0.58-2.11) | .76 | 1.04 (0.55-1.98) | .90 | 1.97 (0.80-4.83) | .14 | 0.50 (0.18-1.38) | .18 |
| LIT with VEN | 0.71 (0.35-1.43) | .34 | 0.81 (0.42-1.56) | .53 | 1.21 (0.49-3.00) | .68 | 0.54 (0.20-1.43) | .21 |
| HCT-CI Score | ||||||||
| Low-/intermediate-risk (0-2) | Reference | Reference | — | — | ||||
| High-risk (≥3) | 2.09 (1.20-3.65) | .01 | 1.90 (1.11-3.25) | .02 | — | — | ||